ID

34590

Description

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01941199

Link

https://clinicaltrials.gov/show/NCT01941199

Keywords

  1. 1/19/19 1/19/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT01941199

Eligibility Type 2 Diabetes Mellitus NCT01941199

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 20 to 45, healthy male subjects(at screening)
Description

ID.1

Data type

boolean

body weight between 55kg - 90kg, bmi between 18.0 - 27.0
Description

ID.2

Data type

boolean

fpg 70-125mg/dl glucose level(at screening)
Description

ID.3

Data type

boolean

subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, neurology, immunology, pulmonary, endocrine, hematooncology, cardiology, mental disorder)
Description

ID.5

Data type

boolean

subject who had gi tract disease(crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
Description

ID.6

Data type

boolean

subject who had drug(aspirin, antibiotics) hypersensitivity reaction
Description

ID.7

Data type

boolean

subject who already participated in other trials in 2 months
Description

ID.8

Data type

boolean

subject who had whole blood donation in 2 months, or component blood donation in 1 months or transfusion in 1 months currently.
Description

ID.9

Data type

boolean

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01941199

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age between 20 to 45, healthy male subjects(at screening)
boolean
ID.2
Item
body weight between 55kg - 90kg, bmi between 18.0 - 27.0
boolean
ID.3
Item
fpg 70-125mg/dl glucose level(at screening)
boolean
ID.4
Item
subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, neurology, immunology, pulmonary, endocrine, hematooncology, cardiology, mental disorder)
boolean
ID.6
Item
subject who had gi tract disease(crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
boolean
ID.7
Item
subject who had drug(aspirin, antibiotics) hypersensitivity reaction
boolean
ID.8
Item
subject who already participated in other trials in 2 months
boolean
ID.9
Item
subject who had whole blood donation in 2 months, or component blood donation in 1 months or transfusion in 1 months currently.
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial